Results 51 to 60 of about 724,601 (205)

Photonic Si microwell architectures for rapid antifungal susceptibility determination of Candida auris [PDF]

, 2023
We present the application of a photonic silicon chip-based optical sensor system for expeditious and phenotypic antifungal susceptibility testing. This label-free diagnostic assay optically monitors the growth of Candida auris at varying antifungal ...
Scheper, Thomas, Bahnemann, Janina, Segal, Ester, Heuer, Christopher, Jiang, Xin, Ron, Gali, Ternyak, Orna   +6 more
core   +1 more source

Isolation of Candida africana in oral candidiasis: First report among cancer patients in Iran [PDF]

Current Medical Mycology, 2020
Background and Purpose: Oropharyngeal candidiasis (OPC) is a fungal infection of the oral cavity caused by the members of C. albicans complex. Although C.
Ensieh lotfali, Masoud Mardani, sara Abolghasemi, David Darvishnia, Mohammad Mahdi Rabiei, Reza Ghasemi, Azam Fattahi   +6 more
doaj   +1 more source

Determination of antifungal susceptibility patterns among the clinical isolates of Candida species

Journal of Global Infectious Diseases, 2011
Context: Candida species are opportunistic yeasts that cause infections ranging from simple dermatosis to potentially life-threatening fungemia. The emergence of resistance to antifungal drugs has been increased in the past two decades.
Kamiar Zomorodian, Mohammad Javad Rahimi, Kayvan Pakshir, Marjan Motamedi, Moosa Rahimi Ghiasi, Hasanein Rezashah   +5 more
doaj   +1 more source

Antifungal susceptibility test results for Candida spp. isolates.

, 2019
Antifungal susceptibility test results for Candida spp. isolates.
Luanda Bárbara Ferreira Canário de Souza (7300853), Mariana Araújo Paulo de Medeiros (7300844), Francisco de Assis Bezerra Neto (7300856), Aurélio de Oliveira Bento (7300850), Analy Salles de Azevedo Melo (7300868), Diana Luzia Zuza-Alves (7300862), Elaine Cristina Francisco (7300865), Guilherme Maranhão Chaves (4597957), Ana Patrícia Vieira de Melo (7300847), Jarmilla Bow-Ltaif Garcia (7300859)   +9 more
core   +1 more source

Antifungal susceptibility profile and local epidemiological cut-off values of Yarrowia (Candida) lipolytica: an emergent and rare opportunistic yeast

Microbiology Spectrum
The antifungal susceptibility profile and epidemiological cut-off values (ECOFFs) of Yarrowia lipolytica, a rare opportunistic yeast, remain unclear.
Jinhan Yu, Xueqing Liu, Dawen Guo, Wenhang Yang, Xinfei Chen, Guiling Zou, Tong Wang, Shichao Pang, Ge Zhang, Jingjing Dong, Yingchun Xu, Ying Zhao   +11 more
doaj   +1 more source

New approaches for antifungal susceptibility testing [PDF]

Clinical Microbiology and Infection, 2017
Invasive fungal diseases, including those caused by (multi)drug-resistant Candida and Aspergillus species, still represent global public health concerns. Information about the antifungal susceptibility testing (AFST) of fungal isolates must be quickly produced to help clinicians in administrating appropriate antifungal therapies.
Sanguinetti, Maurizio, Posteraro, Brunella   +1 more
openaire   +2 more sources

How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton

, 2021
Background: Antifungal drug resistance in dermatophytes was first reported shortly after the turn of the millennium and has today been reported in Trichophyton and occasionally in Microsporum, but not in Epidermophyton species.
Velegraki, A., the Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST), Kurzai, O., Meletiadis, J., Rogers, T.R., Castanheira, M., Barchiesi, F., Moore, C.B., Lass-Florl, C., Muehlethaler, K., Arendrup, M.C., Friberg, F., Klimko, N., Kahlmeter, G., Guinea, J., Hamal, P., Lagrou, K., Jarv, H., Hilmarsdottir, I., Arikan-Akdagli, S., Matos, T.   +20 more
core   +1 more source

Current Status Of Antifungal Susceptibility Testing Methods [PDF]

, 2007
Antifungal susceptibility testing is a very dynamic field of medical mycology. Standardization of in vitro susceptibility tests by the Clinical and Laboratory Standards Institute (CLSI) and the European Committee for Antimicrobial Susceptibility Testing (
ARIKAN AKDAĞLI, SEVTAP, Arikan, Sevtap, Sevtap Arikan   +2 more
core   +1 more source

Antifungal susceptibility testing and resistance

, 2017
The availability of choice of systemically active antifungal agents and the proliferation in the number of fungal species implicated in invasive disease have meant that clinicians are increasingly looking for guidance from clinical laboratory results to ...
Elizabeth M. Johnson
core   +1 more source

In vitro antifungal susceptibility methods and clinical implications of antifungal resistance [PDF]

Medical Mycology, 2000
As new antifungal agents are introduced for the treatment of infections caused by yeasts and filamentous fungi (moulds), it is important that reliable methods are available for the in vitro testing of both new and established agents. The ultimate goal of in vitro testing is the prediction of the clinical outcome of therapy.
A, Espinel-Ingroff, D W, Warnock, J A, Vazquez, B A, Arthington-Skaggs   +3 more
openaire   +2 more sources